US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist

15.130
0.0000.00%

Trading May 17 16:00 ET

223.75MMarket Cap1.09P/E (TTM)

Merrimack Pharmaceuticals Stock Forum

Trytosaveabit

Mar 27, 2024 16:36

News

$Elevation Oncology (ELEV.US)$ $Merrimack Pharmaceuticals (MACK.US)$ Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan
MT Newswires· 2 mins ago
Merrimack Pharmaceuticals (MACK) said late Wednesday it has received a $225 million milestone payment from Ipsen and called for a special stockholder meeting on May 10 to approve a plan of dissolution.
The milestone payment was due from Ipsen after the US Food and Drug Administration approved Onivyde as a first-line...

Meltyy

Feb 20, 2024 21:07

PDUFA Update…

4 FDA approvals last week
1 PDUFA event left in Feb 2024
Last week’s PDUFAs:
$AstraZeneca (AZN.US)$ : Approved 2/16
⇒ Tagrisso (osimertinib) + chemotherapy
⇒ NSCLC
⇒ sNDA
⇒ PDUFA: Q1 2024
$Iovance Biotherapeutics (IOVA.US)$ : Approved 2/16
⇒ AMTAGVI™ (lifileucel)
⇒ Melanoma
⇒ BLA
⇒ PDUFA: 02/24/24
$ROCHE HOLDING AG (RHHBY.US)$ : Approved 2/16
⇒ Xolair® (omalizumab)
⇒ IgE-mediated food allergy
⇒ sBLA
⇒ PDUFA: Q1 2024
$IPSEY & $Merrimack Pharmaceuticals (MACK.US)$ : Approved 2/13
⇒ ...

Meltyy

Jan 30, 2024 03:28

PDUFA Update…

📌Last week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia (LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies (THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...

Moomoo AI

Nov 2, 2023 22:42

Chairman Gary Crocker highlighted that interest income on cash and short term investments helped offset a significant portion of Q3 operating expenses. He also noted the company keeps observing developments in Ipsen's Onivyde(R) and Elevation's seribantumab programs.

Press Release: Merrimack Reports Third Quarter 2023 Financial Results

BioPharm Insight US

Nov 14, 2022 10:07

Columns Weekly FDA Drug Pipeline Calendar (Nov 14 - Nov 19)

Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Top Medical News of the Week
$Moderna (MRNA.US)$'s new Covid booster triggered a stronger immune response against omicron BA.5 and also appears to work against the emerging BQ.1.1 subvariant, according to the company.
The U.S. Covid public health emergency will remain in place past Jan. 11 after the federal government did no...